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Identification of the Mouse
Neuromuscular Degeneration Gene
and Mapping of a Second Site Suppressor Allele
neurons (SMN) gene (Lefebvre et al., 1995; Thompson
et al., 1995). SMN is widely expressed and is thought
to be involved in the biogenesis of spliceosomal snRNPs
(Fischer et al., 1997; Liu et al., 1997). It has also been
shown to act synergistically with Bcl-2 to protect against
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apoptotic cell death (Iwahashi et al., 1997). Although
genetic heterogeneity is not as marked in SMA as in
ALS, z5% of these childhood onset autosomal reces-Summary
sive SMA families have been shown to be unlinked to
the primary genetic locus at 5q13 (Merette et al., 1994;The nmd mouse mutation causes progressive degen-
Zerres et al., 1997). The adult onset autosomal dominanteration of spinal motor neurons and muscle atrophy.
SMA IV and distal hereditary motor neuropathy (HMNWe identified the mutated gene as the putative tran-
II) are unlinked to 5q13 as well (Kausch et al., 1991;scriptional activator and ATPase/DNA helicase pre-
Timmerman et al., 1992). These data suggest that theviously described as Smbp2, Rip1, Gf1, or Catf1. Muta-
identification of the many genes involved in motor neu-tions were found in two allelesÐa single amino acid
ron disease in human populations will be difficult, espe-deletion in nmdJ and a splice donor mutation in nmd 2J.
cially with regard to rare recessive mutations in whichThe selective vulnerability of motor neurons is striking
human genetic linkage data are scarce.in view of the widespread expression of this gene,
Neuromuscular degeneration, nmd, is a spontaneousalthough the pattern of degeneration may reflect a
autosomal recessive mouse mutation with two indepen-specific threshold since neither allele is null. In addi-
dent alleles discovered at The Jackson Laboratorytion, the severity of the nmd phenotype is attenuated
(Cook et al., 1995). Like the disorders described above,in a semidominant fashion by a major genetic locus
nmd mice develop a progressive motor neuron diseaseon chromosome (Chr) 13. The identification of the nmd
similar to ALS or SMA, in which skeletal muscle atrophygene and mapping of a major suppressor provide new
is secondary to the loss of motor neurons. Mutant miceopportunities for understanding mechanisms of motor
are characterized by a progressive paralysis that initiallyneuron degeneration.
begins with the hindlimbs, and the forelimbs are affected
to a variable degree with paralysis, generally evident
Introduction only toward the later stages of the disease. Homozygous
nmd mutants can be easily distinguished from their lit-
The motor neuron diseases amyotrophic lateral sclero- termate controls at 2 weeks of age by their dorsally
sis (ALS) and spinal muscular atrophy (SMA) are devas- contracted hindlimbs and impaired movement. Affected
tating neurological disorders characterized by muscle mice rarely survive beyond 4 weeks of age. Histopatho-
fiber atrophy secondary to degeneration of the alpha logical analysis of motor neurons in the spinal cord and
motor neurons in the ventral horn of the spinal cord. brain revealed pale-staining nuclei and perikarya of sev-
ALS is further characterized by the additional degenera- eral degenerating alpha motor neurons initially localized
tion of motor neurons in the brain and lateral corticospi- to the lumbar region of the spinal cord and the sympa-
nal tracts (Siddique and Deng, 1996). Several subtypes thetic chain (Cook et al., 1995). The asymmetrical distri-
of these disorders have been defined clinically, and re- bution of affected fibers in right and left muscles and
cent advances have been made in the mapping and the presence of small regenerating fibers intermixed
identification of genes involved in some familial forms with normal-appearing fibers are consistent with ran-
of these diseases (Rosen et al., 1993; Lefebvre et al., dom denervation of muscles resulting in neurogenic at-
1995; Thompson et al., 1995). ALS afflicts z30,000 rophy. Although the exact cause of death of affected
Americans and familial forms of ALS (FALS) account mice is unclear, the labored breathing of some of the
for z5%±10% of all classical ALS cases (Siddique and end-stage disease animals suggest that respiratory fail-
Deng, 1996). Mutations in the ubiquitously expressed ure may be a primary cause.
SOD1 (Chr 21), encoding a mutated Cu/Zn superoxide Here, we report the identification of the nmd gene and
dismutase, have been found in 15%±20% of FALS pa- two independent causative mutations in the nmdJ and
tients (Siddique et al., 1991; Deng et al., 1993; Rosen et nmd2J alleles. High-resolution chromosomal mapping
al., 1993), and recessive juvenile ALS2 and dominant and mutation analysis of candidate genes revealed that
juvenile ALS4 families have been linked to Chr 2q33±q35 the defective gene in nmd mice encodes a ubiquitously
(Hentati et al., 1994) and 9q34 (Chance et al., 1998), expressed DNA helicase/ATPase protein previously identi-
respectively. The remaining 90%±95% of ALS cases are fied as immunoglobulin S-mu binding protein-2. The
classified as sporadic. Smbp2 cDNA has been isolated independently by sev-
The autosomal recessive childhood SMAs (types I, II, eral groups based on the encoded protein's ability to
and III) have been associated with a highly complex bind target DNA fragments and has received several
and deletion-prone locus involving the survival of motor names in the literature: Smbp2 (Fukita et al., 1993; Mi-
zuta et al., 1993), glial factor 1 (Gf1; Kerr and Khalili,
1991), rat insulin enhancer binding protein 1 (Rip1; Shieh* To whom correspondence should be addressed (e-mail: gac@jax.
org and wnf@jax.org). et al., 1995), and cardiac transcription factor 1 (Catf1;
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Figure 1. Genetic and Physical Map of the
nmd Locus
A high-resolution genetic map of the nmd lo-
cus on Chr 19 was constructed by analyzing
the genotype and phenotype of 1524 (BLKS.
B6-nmd2J 3 CAST/Ei) F2 progeny represent-
ing 3048 independent meiotic events with
D19Mit SSLP markers, polymorphic SSLP or
SSCP markers generated from YAC or BAC
end sequences, and candidate cDNAs shown.
The centromere is represented by the dark
circle at the top, and genetic distances be-
tween markers are given in centimorgans on
the right. The 95% confidence interval for the
nmd mutation around the nonrecombinant
marker D19Mit32 is shown to the left (0.1 cM,
z200 kb; assuming 1 cM 5 2000 kb). Poten-
tial candidate genes ruled out by placement
on the physical map or by recombination
events include carnitine palmitoyl transferase
I (Cpt1a), lymphocyte phosphatase-associ-
ated phosphoprotein (Lpap), deleted in oral
cancer 1 (Doc1), and galanin (Galn). The ori-
entation of end sequences from the BAC
clones are designated F or R, which corre-
sponds to the M13 forward or reverse primer-
containing ends, and YAC ends are desig-
nated L or R, which correspond to the left or
right ends, respectively.
Sebastiani et al., 1995). While this widely expressed DNA Results
binding protein has been implicated in transcriptional
activation and immunoglobulin class switching, its true High-Resolution Genetic and Physical Map
of the nmd Locusbiological activity is not known. Members of the DNA
helicase/ATPase superfamily are known to be involved To fine map nmd, the initial (B6.BLKS-nmd2J 3 CAST/
Ei) F2 mapping cross that localized nmd to Chr 19 (Cookin many cellular activities, including DNA replication,
repair, recombination, and transcriptional activation. et al., 1995) was expanded by genotyping and examining
the phenotype of 1524 interspecific F2 progeny repre-Some members of this family contain multiple functions,
including TFIIH in general transcription, DNA repair, and senting 3048 independent meiotic events. The segrega-
tion of the recessive impaired locomotor phenotype wasapoptosis and SV40 T antigen in viral replication, gene
expression, and tumor suppressor binding (reviewed examined, and all proximal D19Mit SSLP markers and
polymorphic SSLP or SSCP markers generated fromby Fanning and Knippers, 1992; Svejstrup et al., 1996;
Warbrick, 1996). We also report that the severity of the yeast artificial chromosome (YAC) or bacterial artificial
chromosome (BAC) end sequences and candidate cDNAsnmd phenotype can be suppressed in a semidominant
fashion by a modifier gene on Chr 13 and that this sup- (described below) were examined for evidence of re-
combination around the nmd locus. In the resulting map,pression is not simply due to amelioration of the nmd2J
splicing defect. Thus, the nmd mouse and the Mnm D19Mit32 was inseparable from nmd (upper 95% confi-
dence interval of 0.1 cM or z200 kb), and the locationmodifier gene will provide a unique opportunity to iden-
tify specific genetic mechanisms underlying motor neu- of nmd near the centromere left us without an obvious
centromeric marker (Figure 1).ron degeneration.
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Figure 2. Expression of Smbp2 mRNA in
nmd2J Brain and Spinal Cord Reveals Re-
duced Message Levels and Aberrant Splicing
(A) Northern blot analysis of total RNA using
a 39 Smbp2 cDNA probe (clone 17J, de-
scribed in Experimental Procedures) demon-
strated a z20% reduction in the levels of ap-
parently normal-sized (4.5 kb) mRNA from the
spinal cord and brain of nmd2J mutants (m)
compared to B6 controls (wt). The filter was
stripped and rehybridized with a probe for
b-actin as a control for equal loading (below),
and the migration of the 18S and 28S ribo-
somal RNA bands are indicated to the left.
(B) RT±PCR of brain and spinal cord cDNA
with Smbp2 primers spanning exons 3 to 5
(F14 and R3, 191 bp) and exons 4 to 5 (F4 and
R3, 101 bp) revealed a wild-type (wt) fragment
and an aberrantly spliced mutant-specific
fragment (m) 23 bp larger than expected in
both severely affected (MnmB/MnmB) and
mildly affected (MnmC/MnmC) nmd2J mice.
The ratios of spliced products (75%±80% mu-
tant splicing and 20%±25% wild-type splic-
ing) in nmd2J mice were consistent between
the two primer pairs in three replicate experi-
ments and across multiple tissues (liver, kidney, lung, heart, spleen, muscle, and thymus; data not shown). RT±PCR products were uniformly
labeled with [a-32P]dCTP run on 6% polyacrylamide sequencing gels, and autoradiographic bands were quantitated by densitometry.
To establish a physical map of the region, YAC and embryo. From BAC 10H, 13 of the 22 initial clones identi-
fied were from the Cpt1a gene. Of over 100 clones se-BAC clones were isolated using D19Mit32 as an entry
point. YAC and BAC end sequences were used to gener- quenced from BAC 6B, 41 were from the Smbp2 gene
(described below). Of the remaining clones identifiedate sequence tagged sites (STS) to begin a chromosome
walk and to test for database homologies (Figure 1). YAC (Figure 1), three cDNAs were selected by a cytochrome
c oxidase 6a pseudogene, a large contig of cDNAs (864end D6R crossed eight of the eleven distal recombinants
between D19Mit32 and D19Mit93 and provided a distal bp) identical to several mouse ESTs (represented by
EST-mw71d12, GenBank accession number AA209103)physical anchor for the contig. Six BACs were identified
using D6R, and four BACs were identified with D19Mit32, was designated ª16J,º and several unique cDNAs (17P,
17O, 19A, 17H, and 16B) with no homologies in theof which 10H (100 kb) and 6B (250 kb) were characterized
in detail. The distal end sequence of BAC 6B (F) included databases were also found. Using the genetic and physi-
cal maps constructed for the nmd locus, several candi-a 196 bp exon homologous to the rat mitochondrial
carnitine palmitoyl transferase I cDNA (Cpt1a, accession dates from mouse and human homology maps were
also present on the physical map but were excludednumber L07736), and its location on the map allowed
us to rule it out as a possible nmd candidate (Figure 1). from the critical interval as they were separated from
nmd by genetic recombination. Candidates includedThe proximal end of BAC 6B (R) contained the promoter
and first exon of a mouse immunoglobulin kappa light lymphocyte phosphatase-associated phosphoprotein
(LPAP), deleted in oral cancer 1 (Doc1), and galaninchain variable gene segment and an inserted IAP repeti-
tive element. The mouse Igk-V locus maps to Chr 6; (Galn) (described in Experimental Procedures and Fig-
ure 1).however, a large ancestral genomic duplication and trans-
location created a cluster of orphan Vk gene segments
on mouse Chr 19 and Chr 16 (Schupp et al., 1997). Identification of the nmd2J Mutation in Smbp2
Unique gene-containing sequences have not been iden- The only two candidate genes that were nonrecombi-
tified proximal to this large Vk duplicated region on Chr nant with nmd were a novel gene, ª16J,º and Smbp2,
19 or to the marker D19Mit32, suggesting that the geno- both of which were ubiquitously expressed (Mizuta et
mic walk to completely contain nmd was likely finished. al., 1993; Mohan et al., 1998; data not shown). No differ-
Therefore, identification of all of the genes in the interval ences were detected in the expression or sequence
between YAC D6R and the Vk orphan repeat cluster was of the ª16Jº gene in wild-type and nmd2J mutants by
undertaken to examine potential candidate genes for RT±PCR, Northern blot, or DNA sequencing (data not
the nmd mutation. shown), thus excluding ª16Jº as a candidate. Smbp2
arose as a candidate from the comparative maps and
our cDNA selection. This cDNA has been isolated inde-Candidate Genes from cDNA Selection
and Comparative Mapping pendently by several different groups based on its ability
to bind target DNA fragments (Kerr and Khalili, 1991;A modified direct cDNA selection procedure (Lovett et
al., 1991; Morgan et al., 1992) was employed using the Fukita et al., 1993; Sebastiani et al., 1995; Shieh et al.,
1995). This ubiquitously expressed DNA binding proteinoverlapping BAC clones 6B and 10H and pooled RNA
from adult brain, spinal cord, and whole day 10.5 mouse with presumptive helicase motifs is widely expressed
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(high levels in brain, heart, kidney, spleen, and testes impairment of movement. Both male and female mildly
affected mice were fertile, and when mated togetherand lower levels in pancreas, liver, lung, and salivary
gland; Mizuta et al., 1993) and has been implicated in produced only mildly affected offspring (11 out of 11
offspring), suggesting that the mildly affected mice weretranscriptional activation as well as immunoglobulin
class switching; however, its actual biological function homozygous for a single major modifier locus. Endoge-
nous provirus markers were used to perform a genome-is as yet unknown.
Northern blot analysis of Smbp2 revealed a z20% wide scan of DNA from mildly and severely affected mice
to map the putative modifier gene (Table 1). Suggestivereduction in the levels of apparently normal-sized mRNA
from the brain and spinal cord of nmd2J mutants com- linkage to a proviral marker on Chr 13 (data not shown;
Kaushik and Stoye, 1994) was followed by highly signifi-pared to B6 controls (Figure 2A). To screen for a specific
mutation, six sets of overlapping RT±PCR primers span- cant association of other Chr 13 markers with disease
severity (x2[4] 5 31, p , 1.9 3 1027; Table 1; Figure 4).ning the z3 kb coding region were used to amplify and
sequence cDNA from mutant and control mice. No muta- The strong association with Chr 13 loci, coupled with
the prior observation that mildly affected mice ªbreedtions in the coding region were detected, but nmd2J mice
showed an aberrantly spliced message near the 59 end true,º suggests that the Chr 13 modifier gene encodes
a major factor responsible for slowing the progressionof the gene that included 23 additional nucleotides and
a premature stop codon (Figures 2B and 3B). DNA se- of disease in nmd mutant mice. We have designated
the positive modifier allele (mildly affected) from CAST/quencing revealed a single A to G transition mutation
23 bp into intron 4. This mutation creates a cryptic splice Ei MnmC, for modifier of nmd-CAST, and the negative
modifier allele from the C57BL/6J background (severelydonor in nmd2J mutants, thus interfering with the normal
splicing of the message (Figure 2B). Analysis of the tis- affected) MnmB. The Mnm-containing region of mouse
Chr 13 shares homology with four different human chro-sue specificity of this splicing defect by RT±PCR re-
vealed that all tissues (liver, kidney, lung, heart, spleen, mosomal regions, and the comparative map is shown
in Figure 4.muscle, and thymus) display approximately the same
level of abnormal splicing as brain and spinal cord with
20%±25% wild-type splicing and 75%±80% mutant
MnmC Is Semidominantsplicing. In addition, no differences were detected in the
In addition to the very mildly and severely affected micelevel of expression or the ratio of wild-type to mutant
from the F2 cross, approximately half of those affectedspliced forms in mildly and severely affected nmd2J mice
were intermediately or moderately affected as they weredue to their inheritance of a second site modifier gene
able to survive 6±10 weeks compared to 3±4 weeks(described below) in any tissue examined (Figure 2B and
for the severely affected mice. Initial typing of thesedata not shown).
moderately affected mice suggested that their pheno-
type results from a semidominant effect for the MnmSingle Amino Acid Deletion Encoded
modifier, as most of the mice were heterozygous for Chrby the nmdJ Allele
13 markers (data not shown). However, the variationTo gain further evidence that Smbp2 was the nmd gene,
observed in the age of onset and severity of symptomswe sought the mutation in the original nmdJ allele. Since
of these animals might also have been influenced bynmdJ mice are extinct, genomic DNA was used for muta-
either unmapped CAST alleles modifying the phenotypetion screening. By restriction mapping and DNA se-
or environmental or stochastic events.quencing, the Smbp2 gene was found to contain 15
To determine the effect of the CAST-derived MnmCexons and to span z25 kb (Figure 3A). PCR primers
modifier on the nmd phenotype in the absence of allwere designed flanking each of the 15 exons, and the
other CAST alleles, we constructed a congenic B6.CAST-amplification products were tested by SSCP to identify
MnmC line of mice that are homozygous C57BL/6J atdifferences between control CBA/J and mutant CBA/J-
all loci except around the MnmC-containing region wherenmdJ/nmdJ DNA samples. Sequencing revealed a 3 bp
the genome is homozygous CAST (Figure 4). Histologicaldeletion of a CTG triplet in exon 8 that codes for leucine
analysis and gross behavioral observation was done(Figure 3C). Analysis of human and hamster Smbp2
comparing congenic C57BL/6J-nmd2J/nmd2J mice of threecDNA and protein sequences in GenBank revealed that
genotype classes: MnmC/MnmC, MnmC/MnmB, and MnmB/this leucine codon is conserved but is not part of any
MnmB. Histological examination of the limb skeletalrecognized functional domain (Figure 3D).
muscle and spinal cord from doubly homozygous nmd2J,
MnmC mice revealed patches of muscle atrophy andA Genetic Modifier of nmd Maps to Chr 13
occasional dying motor neurons in the spinal cord (ap-While fine mapping nmd, we observed that z20% of
proximately one per 20±30 sections) compared with thethe intersubspecific F2 mice of the nmd2J/nmd2J geno-
severe muscle atrophy and frequent appearance of dy-type were very mildly affected, showing a later onset
ing motor neurons (approximately one per section) evi-and much slower progression of symptoms. These mice
dent in homozygous nmd2J, MnmB mice (Figure 5). Thesedisplayed a similar form of spinal motor neuron degener-
double homozygotes were more severely affected onation as that seen in the severely affected mice; how-
the congenic C57BL/6J background than on the F2ever, fewer degenerating neurons were detected and
cross, living only 2±4 months compared to .7 months,the resulting muscular atrophy was less severe (data
suggesting that the CAST strain contributes additionalnot shown). The mildly affected mice were not pheno-
minor modifier alleles. Nevertheless, in comparing thetypically discernable at weaning and often survived be-
yond 7 months of age with minimal muscle wasting or survival of MnmC/MnmC mice with MnmC/MnmB and
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Figure 3. Smbp2 Gene Structure and Identifi-
cation of nmd2J and nmdJ Mutations
(A) Exon structure and restriction map of the
mouse Smbp2 gene. The restriction map was
determined by Southern blot of single and
double digests of BAC 6B genomic DNA with
the restriction enzymes SmaI (S), EcoRI (E),
HindIII (H), and BamHI (B) probed with over-
lapping cDNA selection clones and RT±PCR
products encompassing the coding and non-
coding regions. Intron/exon boundaries were
determined by subcloning four HindIII restric-
tion enzyme±digested fragments (sizes 2.3,
1.4, 13.7, and 7.7 kb) from BAC 6B and se-
quencing using Smbp2-specific cDNA prim-
ers. Smbp2's fifteen exons (numbered) are
depicted as boxes. Unshaded boxes repre-
sent the 59 and 39 untranslated regions, and
the shaded boxes represent the coding re-
gions.
(B) A single base A to G transition mutation
23 bp into intron 4 (arrow) creates a new fa-
vorable splice donor in the nmd2J mutant
mouse. The exon/intron structure and splice
patterns are shown above and the sequence
of the mutation in context is shown in the
middle from mutant and C57BLKS/J control.
Exon sequences are capitalized and introns
are in lowercase. The splice donor consensus
for wild-type and mutant spliced products are
underlined. The bottom mRNA sequence and
single letter amino acid translation product
are shown for the nmd2J mutant and wild-type
messages. The inclusion of 23 nucleotides of
intron 4 in the Smbp2 message results in a
frameshift, with four unique amino acids
added to the C terminus before terminating
at a UAA (stop) codon.
(C) A 3 bp deletion was identified in exon 8
of the CBA/J-nmdJ mutant mouse (arrows)
that results in the deletion of a single leucine
amino acid (underlined) from the Smbp2
protein.
(D) The aligned amino acid sequences coded for by exon 8 from the mouse, human, and hamster Smbp2 genes are aligned. Amino acid
differences are shown and identical sequences are depicted by dots. The conserved helicase domains C and D are underlined, and the leucine
amino acids affected by the nmdJ mutation are double underlined.
MnmB/MnmB classes, the semidominant model was (n 5 5), 9.2 6 0.3 (n 5 4), and 7.4 6 0.4 (n 5 5) g (F[1,12] 5
94, p , 1 3 1026) compared to 14.4 6 0.6 (n 5 4) g forclear in both the degree of motor impairment and life-
span, with an average age at death (6 SD) of 80.3 6 control littermates. This difference is dramatically de-
picted by the relative sizes of the gastrocnemeus mus-20.6 (n 5 12), 52.5 6 9.9 (n 5 10), and 32.0 6 5.8 (n 5
9) days (F[1,29] 5 83, p , 1 3 1027) for the three groups, cles from littermates of each genotypic class at 4 weeks
of age (Figure 6). The size of each muscle is representa-respectively. The semidominant suppression of the nmd
phenotype is also evident in the mean body weights of tive of the degree of motor neuron loss and subsequent
muscle atrophy that results.each genotypic class at 4 weeks of age of 11.2 6 0.9
Discussion
Table 1. Mapping a Major Modifier of nmd
Genotype Number of Number of By positional cloning, we identified the defective gene
Cross (D13Mit3) Mild Severe in neuromuscular degeneration mutant mice (gene sym-
bol: nmd, Chr 19) as the widely expressed putative tran-F2 B/B 0 14
C/B 2 16 scriptional activator Smbp2, and we mapped a second-
C/C 17 2 site modifier allele (Mnm, Chr 13) that suppressed its
p value 1.9 3 1027 phenotype. Mutations in Smbp2 were found for two in-
N2 C/B 1 8 dependent neuromuscular degeneration allelesÐa sin-C/C 7 0
gle amino acid deletion in the nmdJ allele and a splicep value 0.0007
donor mutation in nmd2J. Although the effect of the single
F2 and N2 combined p value: 3.1 3 1029.
amino acid deletion mutation, nmdJ, on gene expression
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itself (Figure 2B). Whether it affects either the Smbp2
protein directly, or rather contributes to the survival of
motor neurons independently, remains to be deter-
mined. Because the disease severity was greater in
nmd2J/nmd2J, MnmC/ MnmC mice on a C57BL/6J con-
genic background than for mice of the same genotype
in the intersubspecific cross, additional modifier alleles
from CAST must exist. In human cases of ALS and SMA,
the existence of modifier genes is implied by intra- and
interfamilial heterogeneity in age of onset or severity of
symptoms (Appelbaum et al., 1992; Scharf et al., 1998).
Mnm is in a region of Chr 13 that shares homology
with four different human chromosomes and contains
many potential candidate genes (Figure 4). Until a high-
resolution map is constructed, it will be nearly impossi-
ble to assess the relevance of these candidates, given
that Smbp2 is ubiquitously expressed and has only pre-
sumptive roles in either Ig class switching or general
transcriptional activation. However, one potentially in-
teresting mouse mutation that maps near Mnm is the
Figure 4. Genetic Map of the Chromosome 13 Mnm Modifier Locus, progressive motor neuropathy (pmn) gene. The pmn
Human Homologies, and B6.CAST-Mnm Congenic Strain phenotype is very similar to that of nmd, with homozy-
Fifty-one (B6-1/nmd2J 3 CAST/Ei) F2 and 16 1/nmd2J (MnmB/ gotes identifiable at 2±3 weeks with pelvic girdle and
MnmC 3 MnmC/MnmC) N2 mildly affected nmd progeny were typed hindlimb muscle atrophy and becoming paralytic, with
for D13Mit markers. The centromere is represented by the dark death occurring at 6±7 weeks (Schmalbruch et al., 1991).
circle at the top, and genetic distances between markers are given
The motor neuron death in pmn has been described asin centimorgans to the left. The markers D13Mit215 and D13Mit265
an axonal degeneration or ªdying backº neuropathy. Thewere determined to flank the MnmC modifier locus based on recom-
intriguing possibility that the CAST/Ei-derived modifierbination events and contingency table analysis similar to that shown
for Table 1. This region of mouse Chr 13 shares homology with of nmd is an allele of pmn, and thus defining a three allele
four different human chromosomal regions according to the NCBI series pmn . MnmB . MnmC, awaits further genetic
mouse/human homology map (http://www.ncbi.nlm.nih.gov/), shown mapping and identification of the underlying genes.
to the left. Based on this initial genetic map, several genes are
known to map to the region, including nidogen (Nid), ras-like, family
1 (Rasl1), ret finger protein (Rfp), T cell receptor gamma (Tcrg),
Smpb2 as a Putative Transcriptional Activatorinhibin beta-a (Inhba), chorionic somatomammotropin hormone 1
or DNA Helicaseand 2 (Csh1,2), butyrophilin (Btn), prolactin (Prl), Friend MuLV inte-
gration site 1 (Fim1), and HNF-3/forkhead homolog 1 (Hfh1). After The Smbp2 gene was identified by several groups based
ten backcross generations to C57BL/6J and selection for the CAST- on its ability to specifically bind target oligonucleotides
derived MnmC allele using the SSLP markers D13Mit215 and corresponding to immunoglobulin switch regions and
D13Mit265, the rest of the genome should be .99.9% derived from
the binding sites of putative transcriptional activators.the C57BL/6J. The selected CAST interval is shown to the right. The
The widespread expression of Smbp2 and the identifica-markers D13Mit205 and D13Mit179 are B6-like in congenic mice
tion of several unrelated potential downstream tran-and thus define the extent of the CAST-derived interval.
scriptional targets, including human apoA-I in hepatoma
cell lines (Mohan et al., 1998), JC viral early and late
promoters in glia (Kerr and Khalili, 1991), the rat insulinwas not assessed because nmdJ mice are extinct, nmd2J
reduces the amount of functional Smbp2 transcript by II promoter (Shieh et al., 1995), and the cardiac atrial
natriuretic factor promoter (McBride et al., 1993), sug-z80%. The nmdJ mutation, which resides in exon 8
encoding the third and fourth conserved helicase do- gest that one function of Smbp2 is to act as a general
activator or coactivator of transcription in concert withmains, could affect domain conformation or the spacing
between domains, thus reducing the normal activity of tissue-specific transcription factors. The DNA binding
and transcriptional activation domains map to the C-ter-the protein. Alternatively, the nmdJ deletion could merely
destabilize the protein, thus decreasing its half-life. minal third of the protein (Kerr and Khalili, 1991; Mohan
et al., 1998). Interestingly, the site of the nmdJ mutationGene targeting to recreate nmdJ mice or expression of
the mutant gene in cell culture will be necessary to between helicase domains is upstream of the region
defined as critical for transcriptional activation. Thus, ifstudy the effects of this interesting mutation on protein
expression and function. the critical activity of Smbp2 required for motor neuron
survival is transcriptional activation, the nmdJ mutation
could functionally mimic the nmd2J splicing mutation byMnm Suppresses the Phenotypic Effects of nmd 2J
While fine mapping nmd2J, we noticed at least three reducing the amount of active protein by altering its
stability.phenotypic classes of homozygous nmd2J mice in the
intersubspecific cross, with some mutants surviving .7 Alternatively, the potential role of Smbp2 as a DNA
helicase could be more relevant to nmd disease. DNAmonths compared to the usual 3±4 weeks. A semidomi-
nant modifier gene mapping to Chr 13, Mnm, accounted helicases are specialized energy-transducing enzymes
that utilize the energy of nucleotide triphosphate hydro-for much of this survival difference. The modifier gene
did not affect the mRNA expression or splicing of Smbp2 lysis to break hydrogen bonds between base pairs and
Mutations in Smbp2/Catf1/Gf1/Rip1 in nmd Mice
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Figure 5. Histopathology of Skeletal Muscle
and Spinal Cord from Mildly and Severely Af-
fected nmd2J Mice
Hematoxylin- and eosin-stained cross sec-
tions of gastrocnemius skeletal muscle (Sk
Muscle) and lumbar spinal cord from 4-week-
old female B6.CAST-Mnm congenic litter-
mates homozygous nmd2J for Chr 19 and
differing at the Chr 13 modifier locus: MnmC/
MnmC (mild) and MnmB/MnmB (severe). An un-
affected control 1/nmd, MnmB/MnmB lit-
termate is included for comparison. Patchy
muscle atrophy is evident in the mildly af-
fected muscle with small regenerating fibers
intermixed with normal-appearing fibers com-
pared to the uniform diameters of fibers
in the control muscle. In contrast, severely
affected muscles consist almost entirely of
small atrophic fibers at 4 weeks of age. This
is consistent with the random denervation of
muscles and resulting neurogenic atrophy
corresponding to the degree of motor neuron
loss in the mild versus severely affected mice.
Analysis of motor neurons in the lumbar spi-
nal cord revealed pale-staining nuclei and
perikarya of several degenerating alpha mo-
tor neurons (open arrowheads) in the severely
affected mice in nearly every 6 mm serial sec-
tion. However, these same ªfading neuronsº
could be detected in the spinal cord of mildly
affected mice (open arrowheads) once in ev-
ery 20±30 serial sections, often appearing
near normal motor neurons (closed arrows).
The mechanism of cell death is unknown, but
hallmarks of apoptosis including pycnotic or
fragmented nuclei are absent, as are other degenerative signs such as nuclear inclusions or vacuolar degeneration. No inflammatory responses
or proliferation of astrocytes, microgliacytes, or satellite cells was observed around the dying neurons. All images were photographed at the
same magnification; scale bar, 50 mm.
unwind the duplex DNA to assist other enzymes (such 1996; Warbrick, 1996), then the defect might be ex-
pected to be cell autonomous in motor neurons. Inter-as polymerases) that lack this activity. The proteins most
closely related to Smbp2 are anonymous DNA helicases estingly, subtle mutations in two subunits of the ubiqui-
tous TFIIH factor (Xpb/Ercc3 and Xpd/Ercc2) are knownfrom S. cerevisiae and S. pombe (35% and 39% amino
acid identity, respectively; 56% similarity) and one puta- to cause the tissue-specific, neurodevelopmental, brittle
hair disorder trichothiodystrophy (TTD), whereas differ-tive DNA binding protein from Arabidopsis thaliana
(45% identity, 65% similarity) identified as open reading ent mutations in these same genes lead to the more
general DNA repair deficiencies xeroderma pigmento-frames in genomic sequences (accession numbers 465704,
Z98951, and AC005313, respectively). These proteins sum (groups B and D) and the human premature aging
disorder Cockayne syndrome (de Boer et al., 1998a;are shorter than Smbp2 by over 300 amino acids and
are homologous to the portion encoding the ATPase/ Lehmann, 1998). Thus, the cell type±specific neurode-
generation observed in nmd2J mice may result from defi-helicase motifs. Interestingly, the S. cerevisiae putative
helicase was recently identified through biochemical pu- ciencies in specific functions of this protein, whereas
different or null mutations might lead to more wide-rification as the yeast DNA polymerase a-associated
DNA helicase A, thought to be involved in DNA replica- spread disease or embryonic lethality as in the TFIID
Xpd null mouse mutation (de Boer et al., 1998b). Creationtion (Biswas et al., 1997a, 1997b). Helicases involved in
DNA replication such as E. coli DnaB, SV40 T antigen, of targeted disruptions in Smbp2 and cell type±specific
rescue using transgenic or chimeric mice will be neces-and the S. cerevisiae replication helicase HscA are
known to function as hexamers. The nmdJ three nucleo- sary to determine which cell and which enzymatic activ-
ity are the primary determinants for motor neuron dis-tide deletion mutation, which resides between helicase
domains two and three, might destabilize the interac- ease in these mice.
tions of these hexamers and thus reduce the effective
function of Smbp2 below a critical threshold. Search for Downstream Targets of Smbp2
in Motor NeuronsOne caveat to a model involving DNA replication and
helicase activity as critical in nmd disease is that the Neither the pattern of Smbp2 expression nor its possible
biochemical activities suggest an obvious mechanism ofprimary targets may be spinal cord glia and not motor
neurons, as the latter are postmitotic. However, if disease causation. The gene is ubiquitously expressed,
and all tissues showed the same level of defective ex-Smbp2 helicase activity is associated with DNA repair
or apoptosis as described for TFIIH (Svejstrup et al., pression: 20%±25% wild-type splicing and 75%±80%
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Figure 6. Modifier of nmd Dramatically Re-
duces Onset and Rate of Progression of Mus-
cle Wasting
Hematoxylin- and eosin-stained cross sec-
tions of the distal hindlimbs at the level of the
popliteal lymph node from 4-week-old female
B6.CAST-Mnm congenic littermates homo-
zygous nmd2J for Chr 19 and differing only at
the Chr 13 modifier locus: MnmC/MnmC (mild),
MnmC/MnmB (moderate), and MnmB/MnmB
(severe). An unaffected control 1/nmd,
MnmB/MnmB littermate is included for com-
parison. All images were photographed at the
same magnification; scale bar, 1 mm. Struc-
tures identified in the upper left panel: tibia
(T), fibula (F), popliteal lymph node (LN), cra-
nial tibial muscle (CT), deep flexor muscles
(DF), and medial and lateral gastrocnemius
muscles (MG and LG, respectively).
mutant splicing, predicted to reduce the levels of full- locus for familial ALS patients. Despite our initial inability
length protein by $80% in all tissues. Thus, the affected to identify an associated human genetic disorder, the
cell type must be differentially sensitive to this reduction. selective degeneration of motor neurons in this model
If the critical activity of Smbp2 in nmd mice is one of and the dramatic effect that the single Mnm modifier
transcriptional activation, then the motor neuron speci- gene has on the onset and progression of disease in
ficity of the disease might suggest that obvious down- the nmd mouse suggests that targets for intervention
stream targets, such as the SMN gene, would be af- in motor neuron disease exist that can be manipulated
fected in nmd mice. However, RNA expression analysis to alter disease progression.
failed to detect any differences in SMN expression in
Experimental Procedureshomozygous nmd2J mice in the presence or absence of
the MnmC modifier locus (data not shown). Likewise,
Miceno aberrant alternative splicing was detected in the
All mice were obtained from The Jackson Laboratory Mouse Mutantastrocyte-specific glutamate transporter EAAT2 (gene
Resource. The original nmd mutation spontaneously arose in the
symbol SLC1A2; data not shown) as has been demon- CBA/J inbred strain at The Jackson Laboratory, and the second
strated for a majority of sporadic ALS patients (Lin et al., occurrence, nmd2J, was identified in the C57BLKS/J-m db (misty,
1998). Therefore, the identity of relevant motor neuron diabetes) colony. DNA from mutants and sibling controls from the
CBA/J-nmd/1 strain were preserved in TJL DNA Resource, asdisease±specific downstream gene expression targets,
the original nmdJ strain was discarded when it was replaced by thesuch as proteins involved in or regulated by RNA splic-
nmd2J remutation. The C57BL/6J-MnmC congenic strain was con-ing, remains to be discovered. Gene expression display
structed by ten backcross generations of a (B6.BLKS-1/nmd2J 3
technologies provide one approach to finding such tar- CAST/Ei) F2 mouse of genotype nmd2J/nmd2J; MnmC/MnmC to
gets in the future. C57BL/6J with genotypic selection for the CAST-MnmC allele using
Currently, there are no effective treatments or means D13Mit215 and D13Mit265, followed by an intercross to create MnmC
homozygous mice. Although no other chromosomes were deliber-of preventing motor neuron diseases such as ALS or
ately selected, at N8 it was noticed that the nmd2J mutation wasSMA. The identification of Smbp2 as a target for muta-
inadvertently and fortuitously maintained in the stock and thereaftertions causing motor neuron disease in mice will allow for
was included in the genotypic selection. At N10, the unselected
mutation analysis of SMA and HMN II families unlinked to portions of the genome are expected to be .99.9% derived from
5q13 and familial or sporadic ALS patients without SOD1 the C57BL/6J background. The identification of a point mutation in
nmd2J enabled the design of a PCR assay to identify carriers inmutations. The human SMBP2 homolog (gene symbol
unaffected offspring, as the mutation creates a new DdeI restrictionIGHMBP2) is known to map to Chr 11q13.2±q13.4 (Fukita
site that is absent from wild-type mice. The following oligonucleotideet al., 1993). However, preliminary screening of six inde-
primers were used to amplify a 694 bp PCR product from genomicpendent ALS families unlinked to the SOD1 locus with
DNA flanking the mutation: F15 59-GCTGGAAACGATCACATACCG-
markers close to SMBP2 (D11S937 and D11S916) failed 39 and R14 59-AGCTCCTGATGATCCAATGG-39. This PCR assay was
to detect significant linkage (D. Rosen, personal commu- used to identify carriers for setting up informative matings to main-
tain our colonies and to confirm the status of the nmd2J gene innication). Thus, SMBP2 does not appear to be a major
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MnmC/MnmC mildly affected animals. All parental, control, and mu- TAGTCCATGCTAGCCC-39, BAC F21 F F 59-TACACATAGTTGAT
GGGTGG-39 and R2 59-GTTTTCTGTACCTGTACTATG-39, BAC F21tant stocks are maintained at The Jackson Laboratory, where animal
procedures were approved by ACUC. RF 59-TGTTAGGTGTGTTCTGAAG-39 and R 59-CCCTCTCCCAAGC
CACTTG-39, BAC K15 R F 59-AGTTCCATGTCTATGTAACC-39 and
R 59-TCACATTTGCTACAATGTGG-39, and BAC L24 R F 59-ATTHistological Analysis
GTCTGCATCCTTATGCC-39 and R 59-CACTGCCACGAGCACTCFour-week-old affected (severe, intermediate, and mild) and unaf-
AGC9-39.fected littermates from a (B6.CAST-MnmB/MnmC, 1/nmd2J) in-
tercross were deeply anesthetized with Avertin (1.25% tribromoeth-
anol/amyl alcohol) by intraperitoneal injection (0.02 ml/gm) and Direct cDNA Selection
transcardially perfused with phosphate-buffered saline followed by Direct cDNA selection was performed with the BAC clones 6B and
Bouin's fixative. Serial sections (6 mm) were cut from paraffin- 10H as previously described (Morgan et al., 1992; Segre et al., 1995),
embedded spinal cord and gastrocnemeus muscle, mounted, and with the modification that 87.5 mg/ml oligo dT final concentration
stained with hematoxylin and eosin for light microscopic analysis (GIBCO/BRL) was used in place of random hexamers. The starting
according to standard histological procedures. material for the preparation of the cDNA clones was poly(A) mRNA
from adult EL/Suz mouse brain, spinal cord, and CD1 day 10.5 whole
Genetic Mapping mouse embryo. Total RNA was prepared by the Trizol procedure
Genomic DNA was prepared from tail tips using a salt-out procedure (GIBCO/BRL), and poly(A) mRNA was purified using oligo dT cellu-
as previously described (Taylor et al., 1993). REVEAL±PCR was done lose spin columns (Invitrogen). Selected cDNA clones had an aver-
as previously described (Frankel et al., 1994, 1995). Results showing age length of 600±800 bp.
linkage for the Mnm modifier locus were obtained using a 32P end-
labeled oligonucleotide primer from the ETn LTR and an unlabeled
Northern Blot and RT±PCR AnalysisB2 repeat primer (oligonucleotides JS139 and JS134, respectively;
Total RNA was prepared from the brain and spinal cord of 4-week-Kaushik and Stoye, 1994) with 27 mild and 40 severely affected
old nmd2J and 1/1 controls by the Trizol method (Gibco/BRL) ac-mice, summarized in Table 1. SSLP markers (Research Genetics)
cording to the manufacturer's instructions. Total RNA (15 mg) waswere typed on genomic DNA as previously described (Frankel et
separated on a 1.2% agarose/formaldehyde gel and transferred toal., 1994), and gene order was determined by minimizing double
hybond N1 nylon membrane (Amersham) essentially as describedcrossovers. The marker/phenotype association shown in Table 1
(Sambrook et al., 1989). The membrane was probed with the [a-was determined by 2 3 3 contingency table analysis, and inheritance
32P]dCTP (Prime-It, Stratagene) 905 bp cDNA selection clone 17J,models in congenic mice were tested by linear regression analysis.
corresponding to nucleotides 2696±3600 of the mouse Smbp2For construction of a high-resolution genetic map of the nmd locus,
mRNA sequence (accession number L10075). A 1.8 kb mouse1524 (B6.BLKS-nmd2J 3 CAST/Ei) F2 mice were phenotyped and
b-actin probe was labeled and used as a control for equal RNAgenotyped to identify recombinants. F2 mice containing recombi-
loading. For RT±PCR analysis of Smbp2, 1 mg of total brain RNA fromnant genotypes, in which a 1/nmd2J genotype could not be inferred
nmd2J/nmd2J mutants and 1/1 controls was reverse transcribed withunambiguously, were progeny tested (mated to known heterozy-
random hexamers and oligo dT as previously described (Cox et al.,gotes) until mutant progeny or 20±25 unaffected progeny appeared.
1993). Autoradiographic bands were quantitated using a MolecularMap positions of candidate genes were inferred from the Mouse
Dynamics densitometer.Genome Database (http://www.informatics.jax.org/mgd.html). The
following genes and markers were mapped relative to F2 recombi-
nants by SSCP run on nondenaturing MDE gels (AT Biochem) at 40 Smbp2 Genomic Structure and Mutation Screening
W for 3 to 4 hr at 48C: Smbp2 with primers F 59-GGACCTTTTGCGGA The restriction map of the Smbp2 gene was determined by Southern
TTCTGG-39 and R 59-CACGAAACTCTCCACGGTGG-39 (GenBank blot of single and double digests of BAC 6B genomic DNA with
accession number L10075), Galanin (Galn) intron 1 F 59-TCTCACCG the restriction enzymes SmaI, EcoRI, HindIII, and BamHI (Promega)
AGACTTGTCAGG-39 and exon 2 R 59-TTCAGGCAGATCCTCAG probed with overlapping cDNA selection clones and RT±PCR prod-
GTC-39 (accession number L38575, L38576), 16J cDNA selection ucts encompassing the 59 and 39 UTR regions and entire coding
clone 19C intron F 59-CATGCAAGTGCTTATCAGAGG-39 and 19C region (Figure 3A). Intron regions, including intron/exon boundaries,
intron R 59-TGACATCGCAGCAGATAAGG-39, lymphocyte phospha- and 59 and 39 ends were determined by subcloning four HindIII
tase-associated phosphoprotein (LPAP) intron F 59-GAGCTGGTCT restriction enzyme±digested fragments (sizes 2.3, 1.4, 13.7, and 7.7
AGATATCTCC-39 and intron R 59-ACATGCTTGCCAAGCCTGGC-39 kb shown in Figure 3A) from BAC 6B genomic DNA into the HindIII-
(accession number X97268), deleted in oral cancer 1 (Doc1) F 59- digested pBluescript2 vector (GIBCO/BRL). Smbp2-containing
GCAGTAACTGACGGATGTGC-39 and R 59-TTCCAAGCACTCAGT plasmids were identified by PCR with internal exon-specific primers
CATGC-39 (accession number AF011644), YAC D6 right end D6R F followed by automated sequencing using M13 primers and Smbp2-
59-GATGTGGTAATCAGCCTGGC-39 and R 59-ATCACCGTGGGTCC specific cDNA primers to identify intron/exon junctions. Fifteen ex-
CTTTAG-39, and YAC F4 right end by length polymorphism F4R F2 ons were identified and their boundaries, based on the Smbp2 cDNA
59-GAGACAATGAGTAGAGTGGCAGG-39 and R2 59-TTCCTGGCTT sequence (accession number L10075), are as follows for exons 1
GCCATCATCCTC-39. YAC ends were isolated by inverse PCR as through 15: nucleotides 1±206, 207±376, 377±566, 567±664, 665±
described by Letts et al. (1997) and sequenced with an ABI model 828, 829±1029, 1030±1177, 1178±1352, 1353±1535, 1536±1654,
373A automated DNA sequencer (Applied Biosystems). 1655±1749, 1750±1873, 1874±2728, 2729±2898, and 2899±5459.
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